Jubilant Organosys Ltd., an integrated Pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India today announced that it had acquired Speciality Molecules Pvt. Ltd., a niche manufacturer of Speciality Intermediates with manufacturing facilities located in Ambarnath (near Mumbai) in India. The purchase consideration to acquire 100% stake is Rs. 199.5 million on a debt free, cash free basis. The acquired company is engaged in the business of developing, manufacturing and selling of speciality intermediates, which include primarily pyridine derivatives that are used in pharmaceuticals and other life science industry. The acquisition will be accretive to Jubilant's earnings from the date of acquisition and will strengthen Jubilant's ability to provide comprehensive offering of pyridine derivatives to the customers in life science industry.

Commenting on the development, Mr. Shyam S Bhartia, Chairman & Managing Director and Mr. Hari S Bhartia, Co-Chairman & Managing Director of Jubilant Organosys said:
"The acquisition of Speciality Molecules is yet another step in strengthening our global leadership position in pyridine derivatives. This acquisition will further strengthen Jubilant's Halogenation capabilities as we plan to sell and also use these speciality intermediates captively for various life science derivateives which will help us to offer products based on a common platform at very competitive prices to our global customers who are sector leaders in the pharma and agrochemicals business"

About Jubilant Organosys

Jubilant Organosys Ltd. is an integrated pharmaceutical industry player, one of the largest custom research and manufacturing services (CRAMS) and drug discovery and development services companies out of India. The company has a presence across the pharmaceutical value chain for products and services such as exclusive synthesis, contract manufacturing, proprietary products, Active Pharmaceutical Ingredients, generic dosage forms, drug discovery services, drug development services, chemistry services and clinical research services.

Jubilant Organosys has geographically diversified manufacturing facilities in eight locations: Gajraula (UP), Nanjangud (Karnataka), Roorkee (Uttarakhand), Nira (Maharashtra), Udaipur (Rajasthan), Samlaya (Gujrat), Salisbury, state of Maryland (USA) and Spokane, state of Washington (USA). Together, these help Jubilant cater to 130 customers across more than 50 countries around the world.

---ENDS---

For further information please contact:

Disclaimer: Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential product characteristics and uses, product sales potential and target dates for product launch are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Jubilant Organosys may, from time to time, make additional written and oral forward looking statements, including statements contained in the company's filings with the regulatory bodies and our reports to shareholders. The company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

Back